Intranasal administration of naloxone by paramedics

Prehospital Emergency Care

Volumn 6, Issue 1, 2002, Pages 54-58

  Barton, Erik D ^a   Ramos, Joseph ^b   Colwell, Christopher ^b,c   Benson, Jeff ^c   Baily, Jeff ^c   Dunn, William ^c  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

Author keywords

Drug abuse; Intranasal; Naloxone; Opioid; Overdose; Paramedics

Indexed keywords

NALOXONE; OPIATE;

ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG OVERDOSE; EMERGENCY HEALTH SERVICE; HIGH RISK POPULATION; HUMAN; NEBULIZER; OCCUPATIONAL EXPOSURE; OPIATE ADDICTION; PARAMEDICAL PERSONNEL;

EID: 0036140044     PISSN: 10903127     EISSN: None     Source Type: Journal    
DOI: 10.1080/10903120290938797     Document Type: Article

References (49)

1. Intravenous vs. subcutaneous naloxone for out-of-hospital management of presumed opioid overdose
2. The prehospital treatment of heroin overdoses
3. Intralingual naloxone injection for narcotic-induced respiratory depression
4. Submental injection of naloxone
5. Effects of sublingually given naloxone in opioid-dependent human volunteers
6. Treatment of heroin overdose with endotracheal naloxone
7. Endotracheal naloxone for reversal of morphine-induced respiratory depression in rabbits
8. Nebulized naloxone for reversal of narcotic intoxication: Results of a pilot trial
9. Nasal absorption of naloxone and buprenorphine in rats
10. Nasal administration of naloxone is as effective as the intravenous route in opiate addicts
11. Nasal administration of naloxone for detection of opiate dependence
12. Evaluation of the systemic anticholinergic activity of nasally administered ipratropium bromide
13. On the uptake of labeled glucose by the mucose membranes of the nose, mouth, and middle ear
14. Comparison of plasma benzodiezepine concentrations following intranasal and intravenous administration of diazepam to dogs
15. Effect of dose on the nasal absorption of epinephrine during cardiopulmonary resuscitation
16. Peptide hormones: Review of current and emerging uses by nasal delivery
17. The bioavailability of intranasal lignocaine
18. Is intranasal midazolam an effective rescue medication in adolescents and adults with severe epilepsy?
19. Bioavailability of apomorphine following intranasal administration of mucoadhesive drug delivery systems in rabbits
20. Intranasal nitroglycerine attenuates pressor response to tracheal intubation in beta-blocker treated hypertensive patients
21. Occupational blood contact among prehospital providers
22. Occupational infections disease exposures in EMS personnel
23. Intranasal opiates: Old route for new drugs
24. Pre-induction of anesthesia in pediatric patients with nasally administered sufentanil
25. The systemic availability of buprenorphine administered by nasal spray
26. Comparison of meclizine levels in the plasma of rats and dogs after intranasal, intravenous, and oral administration
27. Pharmacokinetics and bioavailability of metoclopramide nasal spray versus metoclopramide intravenous in healthy volunteers and cancer patients [English]
28. Intranasal angiotensin II directly influences central nervous regulation of blood pressure
29. Intranasal delivery of cardiovascular agents: An innovative approach to cardiovascular pharmacotherapy
30. Nifedipine for postoperative blood pressure control following coronary artery vein grafts
31. Intranasal nitroglycerine attenuates pressor response to tracheal intubation in beta-blocker treated hypertensive patients
32. Improvement in exercise tolerance and immediate beta-adrenergic blockade with intranasal propranolol in patients with angina pectoris
33. Pharmacodynamics of acute intranasal administration of verapamil: Comparison with i.v. and oral administration
34. Evaluation of the systemic anticholinergic activity of nasally administered ipratropium bromide
35. Comparison of intravenous and intranasal administration of epinephrine during CPR in a canine model
36. The bioavailability of intranasal lignocaine
37. Transnasal butorphanol in the emergency department management of migraine headache
38. Dihydroergotamine nasal spray for the acute treatment of migraine
39. Rapid and sustained relief of migraine attacks with intranasal lidocaine: Preliminary findings
40. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses
41. Different absorption of radioactively labeled glucose by human nasal mucosa with acid and alkaline pH values
42. Glucose recovery after intranasal glucagon during hypoglycaemia in man
43. Pharmacokinetic and pharmacodynamic response after intranasal administration of diazepam to rabbits
44. Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children
45. Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients
46. Intranasal administration of diazepam aiming at the treatment of acute seizures: Clinical trials in healthy volunteers
47. Intranasal midazolam in patients with status epilepticus
48. An experimental study on nasal absorption of gentamycin in dogs
49. Efficacy of intranasal administration of neostigmine in myasthenic patients